These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7614851)

  • 21. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin as a renal growth promoting factor.
    Wolf G
    Adv Exp Med Biol; 1995; 377():225-36. PubMed ID: 7484425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].
    Nakagawa S
    Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.
    Nakagawa S; Nishihara K; Miyata H; Shinke H; Tomita E; Kajiwara M; Matsubara T; Iehara N; Igarashi Y; Yamada H; Fukatsu A; Yanagita M; Matsubara K; Masuda S
    PLoS One; 2015; 10(8):e0136994. PubMed ID: 26317775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
    Jin Z; Gu C; Tian F; Jia Z; Yang J
    Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.
    Shankland SJ; Wolf G
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F515-29. PubMed ID: 10751212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
    Poolman RA; Brooks G
    J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury.
    Jang HS; Han SJ; Kim JI; Lee S; Lipschutz JH; Park KM
    Biochim Biophys Acta; 2013 Dec; 1832(12):1998-2008. PubMed ID: 23851027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease.
    Hirschberg R; Wang S
    Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):43-52. PubMed ID: 15586015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats.
    Ding G; Franki N; Kapasi AA; Reddy K; Gibbons N; Singhal PC
    Exp Mol Pathol; 2001 Feb; 70(1):43-53. PubMed ID: 11170790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose.
    Chen S; Hoffman BB; Lee JS; Kasama Y; Jim B; Kopp JB; Ziyadeh FN
    Kidney Int; 2004 Apr; 65(4):1191-204. PubMed ID: 15086458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of keratinocyte growth factor-like substance extracted from rabbit liver on renal tubular cell growth during compensatory renal hyperplasia.
    Kanda S; Igawa T; Kanetake H; Saito Y
    Int J Urol; 1997 Jul; 4(4):380-7. PubMed ID: 9256328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of osthole on advanced glycation end products-induced renal tubular hypertrophy and role of klotho in its mechanism of action.
    Kan WC; Hwang JY; Chuang LY; Guh JY; Ye YL; Yang YL; Huang JS
    Phytomedicine; 2019 Feb; 53():205-212. PubMed ID: 30668400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation.
    Ruiz-Ortega M; Bustos C; Plaza JJ; Egido J
    Nephrol Dial Transplant; 1998 Apr; 13(4):886-92. PubMed ID: 9568845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
    Strutz F; Zeisberg M; Ziyadeh FN; Yang CQ; Kalluri R; Müller GA; Neilson EG
    Kidney Int; 2002 May; 61(5):1714-28. PubMed ID: 11967021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stat3 Controls Tubulointerstitial Communication during CKD.
    Bienaimé F; Muorah M; Yammine L; Burtin M; Nguyen C; Baron W; Garbay S; Viau A; Broueilh M; Blanc T; Peters D; Poli V; Anglicheau D; Friedlander G; Pontoglio M; Gallazzini M; Terzi F
    J Am Soc Nephrol; 2016 Dec; 27(12):3690-3705. PubMed ID: 27153926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.